Received May 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
User claims to have had the shingles vaccine three times, and won't do it anymore.; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of extra dose administered in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on unknown date) and Shingrix (received second dose on unknown date). On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: User claims to have had the shingles vaccine three times, and won't do it anymore.). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 04-MAY-2026 This case was reported by a patient via interactive digital media. The patient had the shingles vaccine three times, and won't do it anymore. The batch number was not provided, and we are unable to contact the reporter.